SCHEMBL9506697

SCHEMBL9506697

CCCc1c(OCCCCCc2c(O)c(O)c(Cl)c(Cl)c2Cl)ccc(C(=O)O)c1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.54
CYSLTR2 Q9NS75 10/20 0.53
CYSLTR1 Q9Y271 10/20 0.53
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
NFKB1 P19838 1/20 0.49
PPARG P37231 1/20 0.49
BLM P54132 1/20 0.49
PPARD Q03181 1/20 0.49
PPARA Q07869 1/20 0.49
MEN1 O00255 1/20 0.48
GLA P06280 1/20 0.48
CYP3A4 P08684 1/20 0.48
ALOX5 P09917 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
PTGS1 P23219 1/20 0.48
PTGS2 P35354 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510551 0.91 CYSLTR2 (0.61) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9507999 0.87 CYSLTR2 (0.52) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9508078 0.86 GRM2 (0.52) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9506954 0.83 GRM2 (0.53) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9508053 0.83 GRM2 (0.53) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9558413 0.82 PDE5A (0.51) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9508043 0.81 CYSLTR2 (0.52) GRM2CYSLTR2CYSLTR1LMNAMAPT
SCHEMBL9557975 0.81 PDE5A (0.52) GRM2CYSLTR2CYSLTR1LMNACYP1A2
SCHEMBL9510512 0.81 CYSLTR2 (0.49) GRM2CYSLTR2CYSLTR1LMNAPPARG
SCHEMBL9508087 0.81 CYSLTR2 (0.53) GRM2CYSLTR2CYSLTR1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5025036-A Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-06-18 US claimed
EP-0310126-B1 DERIVATIVES OF PYROCATECHOL-CARBOXYLIC ACID, THEIR PREPARATION AND USE AS ACTIVE INGREDIENTS IN MEDICINES F. HOFFMANN-LA ROCHE AG (CH) 1993-08-18 EP disclosed
US-5191108-A Lipoxygenase inhibitors, antiinflammatory agents HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
US-5025036-A Antiinflammatory agents, gastrointestinal, cardiovascular and skin disorders HOFFMANN-LA ROCHE INC. (US) 1991-06-18 US disclosed
EP-0310126-A2 Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines F. HOFFMANN-LA ROCHE AG (CH) 1989-04-05 EP disclosed